These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19668929)

  • 1. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
    Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
    Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
    [No Abstract]   [Full Text] [Related]  

  • 2. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination: A durable design.
    Sanderson K
    Nature; 2012 Aug; 488(7413):S7. PubMed ID: 22932439
    [No Abstract]   [Full Text] [Related]  

  • 5. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
    Vetter KM; Geller SE
    J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against human papillomavirus.
    Mello CF
    Einstein (Sao Paulo); 2013 Dec; 11(4):547-9. PubMed ID: 24488402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and prevention of Human Papillomavirus.
    Manini I; Montomoli E
    Ann Ig; 2018; 30(4 Supple 1):28-32. PubMed ID: 30062377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe.
    Soldan K; Dillner J
    Euro Surveill; 2006 Nov; 11(11):E061123.3. PubMed ID: 17213557
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytology and DNA HPV-testing in the era of HPV-vaccine].
    Spaczyński M; Malkowska-Walczak B; Nowak-Markwitz E
    Ginekol Pol; 2007 Sep; 78(9):696-700. PubMed ID: 18159823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical approval: Trials of an anticancer jab.
    Clayton J
    Nature; 2012 Aug; 488(7413):S4-6. PubMed ID: 22932438
    [No Abstract]   [Full Text] [Related]  

  • 13. Mandating HPV vaccination: what are the arguments?
    Smith CM
    J Christ Nurs; 2008; 25(2):74-80; quiz 81-2. PubMed ID: 18401926
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond resumption of the Japanese Government's recommendation of the HPV vaccine.
    Ueda Y; Yagi A; Ikeda S; Enomoto T; Kimura T
    Lancet Oncol; 2018 Dec; 19(12):1563-1564. PubMed ID: 30507414
    [No Abstract]   [Full Text] [Related]  

  • 15. The new HPV vaccination.
    Bedford H
    Community Pract; 2008 Aug; 81(8):36-7. PubMed ID: 18834017
    [No Abstract]   [Full Text] [Related]  

  • 16. Realities of alternative HPV vaccination schedules.
    Stanley M
    Salud Publica Mex; 2018; 60(6):617-620. PubMed ID: 30699265
    [No Abstract]   [Full Text] [Related]  

  • 17. Public health: Prevention comes of age.
    Eisenstein M
    Nature; 2012 Aug; 488(7413):S11-3. PubMed ID: 22932434
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination of cervical cancer depends on HPV vaccination and primary HPV screening.
    Harper DM; Jimbo M
    Lancet Infect Dis; 2021 Oct; 21(10):1342-1344. PubMed ID: 34081924
    [No Abstract]   [Full Text] [Related]  

  • 19. HPV single-dose vaccination: Impact potential, evidence base and further evaluation.
    Stanley M; Dull P
    Vaccine; 2018 Aug; 36(32 Pt A):4759-4760. PubMed ID: 29754700
    [No Abstract]   [Full Text] [Related]  

  • 20. Papillomavirus vaccine for women, and for men?
    Hidalgo Tenorio C
    Med Clin (Barc); 2019 Apr; 152(7):264-265. PubMed ID: 30591274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.